Su1930 – Safety and Efficacy of Olorinab, a Peripherally Restricted, Highly Selective, Cannabinoid Receptor 2 Agonist in a Phase 2A Study in Chronic Abdominal Pain Associated with Crohn’s Disease
| Autor: | Yacyshyn, Bruce, Ginsberg, Daniel C., Gilder, Kye, Walsh, Brandon, English, Brett, Turner, Stewart A., Klassen, Preston, Hanauer, Stephen B., Barish, Charles F., Higgins, Peter D. |
|---|---|
| Zdroj: | In Gastroenterology May 2019 156(6) Supplement 1:S |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|